Latest Form 4 insider transactions
NASDAQ
Helmy Eltoukhy, Co-Chief Executive Officer and a Director of Guardant Health, Inc., reported multiple transactions in common stock on August 11, 2026.
NYSE
John G Danhakl, a Director of Life Time Group Holdings, Inc., sold 5,119,099 shares of common stock on August 10, 2026 for $43.16 per share.
NYSE
Kelly Youngblood, See Remarks of Centuri Holdings, Inc., received 72,864 shares of common stock on August 12, 2026.
NASDAQ
Amirali Talasaz, Co-Chief Executive Officer and a Director of Guardant Health, Inc., reported multiple transactions in common stock on August 10, 2026.
NYSE
Danielle E. Hunter, See Remarks of Centuri Holdings, Inc., reported multiple transactions in common stock on August 12, 2026.
NASDAQ
John G. Saia, Chief Legal Officer of Guardant Health, Inc., reported a transaction in 800 shares of common stock on August 10, 2026.
NASDAQ
Gilbert E Nathan, a Director of Alto Ingredients, Inc., purchased 50,000 shares of common stock on August 11, 2026 for $4.15 per share.
NYSE
Green LTF Holdings II LP and 9 others reported changes in beneficial ownership of Life Time Group Holdings, Inc. common stock on August 10, 2026.
NASDAQ
Daniel Gizinski, President, S&S Comm. Segment of Comtech Telecommunications Corp /De/, reported multiple transactions in common stock on August 11, 2026.
NASDAQ
Richard K Prins, a Director of Amphastar Pharmaceuticals, Inc., sold 7,973 shares of common stock on August 11, 2026 for $20.30 per share.
NASDAQ
Michael Bondi, Chief Financial Officer of Comtech Telecommunications Corp /De/, reported multiple transactions in common stock on August 11, 2026.
NASDAQ
Donald E. Walther, Chief Legal Officer of Comtech Telecommunications Corp /De/, reported multiple transactions in common stock on August 11, 2026.
NASDAQ
David Zaslav, Chief Executive Officer & Pres and a Director of Warner Bros. Discovery, Inc., sold 153 shares of common stock on August 22, 2024 for $7.55 per share.
NYSE
Jay A. Bys, EVP & Chief Commercial Officer of California Resources Corp, sold 11,907 shares of common stock on August 10, 2026 for $54.00 per share.
NASDAQ
Gerhard Zeiler, President, International of Warner Bros. Discovery, Inc., sold 591,038 shares of common stock on August 10, 2026.
NASDAQ
Kenneth W Lowe, a Director of Warner Bros. Discovery, Inc., sold 120,000 shares of common stock on August 11, 2026 for $26.97 per share.
NASDAQ
ANNX
Annexon, INCMark S. Blumenkranz, a Director of Annexon, Inc., received 175,000 shares of common stock on August 10, 2026.
NASDAQ
Piazza Samuel A Di Jr., a Director of Warner Bros. Discovery, Inc., reported a transaction in 82,415 shares of common stock on August 11, 2026.
NYSE
Melkeya Mcduffie, Senior VP, Human Resources of Group 1 Automotive Inc, reported a transaction in 24 shares of common stock on August 11, 2026.
NASDAQ
Tushar Bhikhubhai Patel, a 10% owner of Amneal Pharmaceuticals, Inc., received 12,763,469 shares of common stock on August 10, 2026.
NASDAQ
QCOM
Qualcomm Inc/deForm 4: Qualcomm Inc/De CFO Sells Shares
Akash J. Palkhiwala, EVP, CFO & COO of Qualcomm Inc/De, sold 2,500 shares of common stock on August 12, 2026.
NYSE
John G Finley, Chief Legal Officer of Blackstone Inc., sold 45,000 shares of common stock on August 11, 2026.
NYSE
David S. Perpich, a Director of New York Times Co, reported a transaction in 131 shares of common stock on August 10, 2026.
NYSE
David Payne, Chief Accounting Officer of Blackstone Inc., sold 9,500 shares of common stock on August 11, 2026 for $145.23 per share.
NYSE
Form 4: Blackstone Director Buys Shares
Ruth Porat, a Director of Blackstone Inc., purchased 455 shares of common stock on August 10, 2026.
NASDAQ
DUOL
Duolingo, INCSallie Krawcheck, a Director of Duolingo, Inc., reported multiple transactions in common stock on August 10, 2026.
OQX
TSNDF
Terrascend CORPZiad Ghanem, President and CEO and a Director of TerrAscend Corp., received 350,000 shares of common stock on August 10, 2026.
NASDAQ
Form 4: ProFrac Holding CEO Buys Shares
Matthew Wilks, Chief Executive Officer and a Director of ProFrac Holding Corp., purchased 80,000 shares of common stock on August 10, 2026.
NASDAQ
Gregory L. Jackson, a Director of PERDOCEO EDUCATION Corp, sold 11,271 shares of common stock on August 11, 2026 for $31.78 per share.
NASDAQ
Sean F. Scanlan, Chief Innovation Officer of Treace Medical Concepts, Inc., reported a transaction in 9,814 shares of common stock on August 9, 2026.